Gotham Asset Management’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-25,368
Closed -$1.23M 1391
2022
Q4
$1.23M Buy
25,368
+3,493
+16% +$219K 0.03% 608
2022
Q3
$1.54M Buy
+21,875
New +$1.87M 0.05% 487
2022
Q2
Sell
-18,504
Closed -$1.48M 1246
2022
Q1
$1.48M Sell
18,504
-7,939
-30% -$591K 0.05% 440
2021
Q4
$2.41M Buy
26,443
+4,022
+18% +$432K 0.08% 307
2021
Q3
$2.88M Buy
22,421
+20,300
+957% +$2.84M 0.12% 228
2021
Q2
$323K Buy
+2,121
New +$279K 0.01% 820
2020
Q3
Sell
-3,723
Closed -$229K 1129
2020
Q2
$229K Sell
3,723
-19,537
-84% -$798K 0.01% 921
2020
Q1
$750K Buy
23,260
+15,769
+211% +$531K 0.02% 627
2019
Q4
$263K Buy
+7,491
New +$247K ﹤0.01% 971
2019
Q3
Sell
-11,548
Closed -$339K 1211
2019
Q2
$339K Sell
11,548
-8,560
-43% -$247K 0.01% 911
2019
Q1
$687K Sell
20,108
-11,647
-37% -$412K 0.01% 764
2018
Q4
$1.01M Buy
31,755
+7,568
+31% +$295K 0.02% 626
2018
Q3
$1.16M Buy
24,187
+14,113
+140% +$578K 0.02% 587
2018
Q2
$312K Buy
+10,074
New +$236K ﹤0.01% 773

Other funds holding STAA

Gotham Asset Management's STAA Position: Q1 2023 in Review

Gotham Asset Management sold out of STAAR Surgical (STAA) in Q1 2023, closing a stake of 25,368 shares — an estimated $1.23M sold.

Gotham Asset Management first reported a position in STAA in Q2 2018 and held it in 14 quarters. The position peaked at $2.88M in Q3 2021. 251 funds tracked by Wall St. Rank hold STAA as of Q1 2023.

  • Gotham Asset Management reported no remaining STAAR Surgical position as of Q1 2023 after selling out during the quarter.
  • Gotham Asset Management sold 25,368 STAAR Surgical shares in Q1 2023, an estimated $1.23M.
  • Gotham Asset Management first reported a position in STAAR Surgical in Q2 2018 and held it in 14 quarters.
  • Gotham Asset Management's STAAR Surgical position peaked at $2.88M in Q3 2021.
  • 251 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2023.

Based on Gotham Asset Management's 13F filing for Q1 2023, filed 15 May 2023.